Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Intravenous Immunoglobulin (IVIG) in Combination Therapy With Antibacterial Agents for Surgical Site Infection of the Lower Digestive Tract

NCT00511212 is registered in ClinicalTrials.gov with Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group as lead sponsor.

NCT NCT00511212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00511212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Intravenous Immunoglobulin (IVIG) in Combination Therapy With Antibacterial Agents for Surgical Site Infection of the Lower Digestive Tract
Lead sponsor
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
Phase
Not applicable
Overall status
Withdrawn
Start date
August 31, 2007
Completion date
June 30, 2009
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peritonitis, postoperative complications